Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Alicja Zalewski"'
Autor:
John C. Flickinger, Ross E. Staudt, Jagmohan Singh, Robert D. Carlson, Joshua R. Barton, Trevor R. Baybutt, Jeffrey A. Rappaport, Alicja Zalewski, Amanda Pattison, Scott A. Waldman, Adam E. Snook
Publikováno v:
npj Vaccines, Vol 7, Iss 1, Pp 1-10 (2022)
Abstract Strategies to augment immunity to self/neoantigens expressed by cancers are urgently needed to expand the proportion of patients benefiting from immunotherapy, particularly for GI cancers where only a fraction of patients respond to immunoth
Externí odkaz:
https://doaj.org/article/e22b2a072d4641808bb7b166089c9d83
Autor:
Robert Carlson, Adam Snook, Trevor Baybutt, Scott Waldman, Amanda Lisby, Megan Weindorfer, Alicja Zalewski
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 8, Iss Suppl 3 (2020)
Externí odkaz:
https://doaj.org/article/74cc85a886b442009f650fe93afeb8a9
Autor:
Robert Carlson, Adam Snook, Trevor Baybutt, Scott Waldman, Amanda Lisby, Megan Weindorfer, Alicja Zalewski, Madison Crutcher, David Loren, Ernest Rosato, Nathaniel Evans
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 8, Iss Suppl 3 (2020)
Externí odkaz:
https://doaj.org/article/3096a4516cac4ef7b222da76cef2a913
Autor:
Scott A. Waldman, Amanda M. Pattison, Jeffrey A. Rappaport, Joshua R Barton, Alicja Zalewski, Adam E. Snook, Ariana A Entezari
Publikováno v:
Cancer Biology & Therapy. 21:799-805
Most sporadic colorectal cancer reflects acquired mutations in the adenomatous polyposis coli (APC) tumor suppressor gene, while germline heterozygosity for mutant APC produces the autosomal dominant disorder Familial Adenomatous Polyposis (FAP) with
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ad9c3d82c510340367fe6372d189e1ee
https://doi.org/10.1080/15384047.2020.1779005
https://doi.org/10.1080/15384047.2020.1779005
Autor:
Alicja Zalewski, Caitlyn Costanzo, Arturo J. Rios-Diaz, Charles J. Yeo, Lisa A. Bevilacqua, Francesco Palazzo, David Metcalfe
Publikováno v:
Journal of the American College of Surgeons. 233:e26-e27
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d346345e9d12f1f564241aa85df572c9
https://doi.org/10.1016/j.jamcollsurg.2021.08.073
https://doi.org/10.1016/j.jamcollsurg.2021.08.073
Publikováno v:
Per Med
Colorectal cancer continues to represent a significant burden on public health as the second highest cause of cancer mortality, when men and women are combined, in the US. About 50% of patients either present with late-stage metastatic disease, or de
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::67f90cc2170139b23e08507f1e022e7d
https://pubmed.ncbi.nlm.nih.gov/33565332
https://pubmed.ncbi.nlm.nih.gov/33565332
Autor:
David E. Loren, Alicja Zalewski, Adam E. Snook, Scott A. Waldman, Megan Weindorfer, Robert D Carlson, Nathaniel R. Evans, Madison Crutcher, Trevor R. Baybutt, Ernest L. Rosato, Amanda Lisby
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 8, Iss Suppl 3 (2020)
Background Esophageal cancer is the fifth most common cause of cancer-related death in the world1 with a 5-year survival rate of Methods To develop esophageal cancer models for GUCY2C immunotherapy testing, esophageal cancer samples were collected at
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::050652ce4da3166df0afbf5caf4f1a3f
https://doaj.org/article/3096a4516cac4ef7b222da76cef2a913
https://doaj.org/article/3096a4516cac4ef7b222da76cef2a913
Autor:
Trevor R. Baybutt, Adam E. Snook, Jonathan Stem, Ellen M. Caparosa, Alicja Zalewski, Scott A. Waldman
Publikováno v:
Regular and young investigator award abstracts.
Background Colorectal cancer (CRC) presents a significant public health burden, responsible for the second most cancer-related deaths in the United States, with an increasing incidence in young adults observed globally.1,2 While the blockade of immun
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::708097bd5142b58984d11394fb291c8a
https://doi.org/10.1136/jitc-2020-sitc2020.0105
https://doi.org/10.1136/jitc-2020-sitc2020.0105
Autor:
Trevor R. Baybutt, Adam E. Snook, Megan Weindorfer, Amanda Lisby, Scott A. Waldman, Alicja Zalewski, Robert D Carlson
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 8, Iss Suppl 3 (2020)
Background Gastric cancer is the sixth most common cancer and second-leading cause of cancer-related mortality worldwide.1 The heterogenous and genetically complex nature of this disease underlies the challenges in developing effective therapies for
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6688d845448cedbc78301ea678ae2199
https://doaj.org/article/74cc85a886b442009f650fe93afeb8a9
https://doaj.org/article/74cc85a886b442009f650fe93afeb8a9
Autor:
Amanda M, Pattison, Joshua R, Barton, Ariana A, Entezari, Alicja, Zalewski, Jeff A, Rappaport, Adam E, Snook, Scott A, Waldman
Publikováno v:
Cancer Biology & Therapy
article-version (VoR) Version of Record
article-version (VoR) Version of Record
Most sporadic colorectal cancer reflects acquired mutations in the adenomatous polyposis coli (APC) tumor suppressor gene, while germline heterozygosity for mutant APC produces the autosomal dominant disorder Familial Adenomatous Polyposis (FAP) with
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::e1d5ebbee2547b1a22e6f6b75523df72
https://pubmed.ncbi.nlm.nih.gov/32594830
https://pubmed.ncbi.nlm.nih.gov/32594830